Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
July 27, 2011, from 8 a.m. to 5 p.m. (Day 2 of 2)
Agenda: On July 27, 2011, the committee will discuss current strategies for FDA’s Office of Pharmaceutical Science implementation of quality by design principles within its review offices, incorporating an update on the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use Activities. The committee will also receive awareness presentations on FDA’s current partnering with the United States Pharmacopeia, principally to discuss the Monograph Modernization Program.
Subscribe to:
Post Comments (Atom)


No comments:
Post a Comment